Come up with a name for your new list and we'll add to it:
Dalriada Therapeutics raised a round of funding on February 20, 2018. Investors include
Fight Against Cancer Innovation Trust.
Dalriada Therapeutics is a pharmaceutical company focusing on the development of small molecule-based anti-cancer therapeutics. It is conducting preclinical and early clinical development of its uniqu…